methylprednisolone has been researched along with Syncope in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Chen, F; Wang, L; Xu, J | 1 |
Ameloot, K; De Wever, W; Goffin, K; Palmers, PJ; Voigt, JU | 1 |
Domen, RE; Javeed, M; Nifong, TP; Rybka, WB | 1 |
Chipps, B | 1 |
Aul, C; Grabensee, B; Königshausen, T; Küppers, H; Scharf, RE | 1 |
Hoffman, RS; Nelson, LS | 1 |
Cruz Caparrós, G; Delgado Fernández, M; Díez García, F; Zambrana García, JL | 1 |
1 review(s) available for methylprednisolone and Syncope
Article | Year |
---|---|
[Postural syncope and dark gingival plaques].
Topics: Addison Disease; Aged; Diagnosis, Differential; Drug Therapy, Combination; Gingival Diseases; Glucocorticoids; Humans; Hydrocortisone; Male; Methylprednisolone; Syncope | 1999 |
6 other study(ies) available for methylprednisolone and Syncope
Article | Year |
---|---|
Acute peripheral pulmonary embolism attributed to autoimmune haemolytic anaemia: a case report.
Topics: Acute Disease; Anemia, Hemolytic, Autoimmune; Anticoagulants; Female; Fibrinolytic Agents; Glucocorticoids; Humans; Methylprednisolone; Middle Aged; Pulmonary Embolism; Shock, Cardiogenic; Syncope; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Warfarin | 2020 |
An echocardiographic finding leading to the diagnosis of giant cell arteritis.
Topics: Aged; Echocardiography, Transesophageal; Fatigue; Follow-Up Studies; Giant Cell Arteritis; Humans; Methotrexate; Methylprednisolone; Positron-Emission Tomography; Risk Assessment; Syncope; Treatment Outcome; Weight Loss | 2013 |
Durable response to combination therapy including staphylococcal protein A immunoadsorption in life-threatening refractory autoimmune hemolysis.
Topics: Acute Disease; Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Angina, Unstable; Autoantibodies; Blood Transfusion; Combined Modality Therapy; Drug Resistance; Hemagglutinins; Hematopoiesis, Extramedullary; Humans; Immunoglobulins, Intravenous; Immunosorbent Techniques; Immunosuppressive Agents; Jaundice; Male; Methylprednisolone; Middle Aged; Plasmapheresis; Prednisone; Remission Induction; Spleen; Splenectomy; Staphylococcal Protein A; Syncope | 2002 |
Systemic reaction to omalizumab.
Topics: Acetates; Adrenal Cortex Hormones; Aged; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Asthma; Cyclopropanes; Depression; Drug Hypersensitivity; Drug Therapy, Combination; Epinephrine; Female; Humans; Hypersensitivity; Hypertension; Methylprednisolone; Omalizumab; Quinolines; Rhinitis; Salmeterol Xinafoate; Seizures; Sulfides; Syncope | 2006 |
[Differential therapy of thrombotic-thrombopenic purpura. Administration of fresh plasma versus plasma separation].
Topics: Acute Kidney Injury; Adult; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Erythrocytes; Heparin; Humans; Immunoglobulin G; Male; Methylprednisolone; Plasma; Plasma Exchange; Plasmapheresis; Platelet Count; Proteinuria; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Syncope; Urine | 1984 |
Intrathecal injection: unusual complication of trigger-point injection therapy.
Topics: Administration, Topical; Adult; Anesthetics, Local; Anti-Inflammatory Agents; Drug Combinations; Facial Pain; Female; Glucocorticoids; Hemiplegia; Humans; Injections, Spinal; Lidocaine; Methylprednisolone; Pneumocephalus; Respiratory Insufficiency; Syncope | 1998 |